{
    "code": "06024316",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06024316",
    "time": "2020-02-25 20:40:45",
    "許可證字號": "衛署醫器輸字第024316號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4062",
    "有效日期": "112\/01\/16",
    "發證日期": "102\/01\/16",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00602431606",
    "中文品名": "中文品名變更：&quot;奧索&quot;紅血球試劑。",
    "英文品名": "“Ortho”Reagent Red Blood Cells Surgiscreen",
    "效能": "用於定性檢測及\/或鑑定非預期的特異血型抗體試劑。",
    "醫器規格": "707950 (3vial*3ml\/pack),6901864 (3vial*10ml\/pack),以下空白\r\n變更規格(規格707950新增適用機型)：詳如中文仿單核定本。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B9175自動血液分類及抗體試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "620118D857  台灣大昌華嘉股份有限公司",
    "申請商地址": "台北市內湖區堤頂大道二段407巷20弄1、3、5、7號10樓及22、24、26號10樓及22號10樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "MUS2652000  ORTHO-CLINICAL DIAGNOSTICS, INC.",
            "製造廠廠址": "1001 U.S. HIGHWAY 202, RARITAN, NEW JERSEY 08869 U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "1076012797-024316(1070906核發)-108-04-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024316&Seq=002&Type=9"
        },
        {
            "title": "1076012797-024316(1070906核發)-108-04-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024316&Seq=002&Type=8"
        }
    ]
}